Abstract
BACKGROUND: Pharmaceutical payments may affect the interpretation of clinical research and prescribing patterns of physicians. Additionally, they may reflect gender disparities in academic dermatology with regard to social recognition and opportunities for career advancement. OBJECTIVE: We examined relationships with industry among male and female journal editors who accepted pharmaceutical payments in leading dermatology journals. METHODS: We assessed the seven US journals among the leading 20 dermatology journals as determined by impact factor and gathered data via the CMS Open Payments dataset. RESULTS: In a cross-sectional study of 329 editors eligible to appear in the Open Payments website, we found that 218 (66.3%) received industry payments totaling $21,952,402. The mean and median dollar value of payments per editor was $100,699 and $3,638 (interquartile range, $364-$57,108). Food and beverage payments accounted for 63.0% of the $28,992 total payments, and the associated dollar value was $887,617 (4.04%). Gender disparities in corporate payments were observed in other contexts, but we did not find a similar relationship among leading dermatology journals. CONCLUSION: Our work highlights that pharmaceutical payments exist among dermatology editors, providing a rationale for future research to address whether editor bias related to pharmaceutical payments exists and more granular studies on the role of gender with regard to navigating such payments.